Intensity-Modulated Radiation Therapy (IMRT) Versus Rapidarc in the Treatment of Carcinoma Left Breast – Finding the Optimal Radiation Therapy Technique

Document Type : Original Paper


1 Consultant Radiation Oncologist, Capitol hospital, Jalandhar, Punjab, India

2 Medical Physicist and RSO, Capitol hospital, Jalandhar, Punjab, India

3 Consultant Cardiologist, Department of Cardiology, Capitol hospital, Jalandhar, Punjab, India

4 Medical Physicist, Capitol hospital, Jalandhar, Punjab, India

5 DNB Resident, Department of Radiation Oncology, Capitol hospital, Jalandhar, Punjab, India


Introduction: This study aimed to evaluate the dosimetric variations and treatment efficacy between intensity-modulated radiotherapy (IMRT) and double-arc RapidArc for irradiation of carcinoma left breast, focusing on adequate target coverage, sparing of organs at risk (OARs), delivered monitor units (MUs) per fraction, and treatment delivery time.
Material and Methods: This prospective, observational study was conducted on 30 patients with carcinoma left breast. All these patients were treated with adjuvant radiation therapy.  We generated two plans for each of these patients: IMRT and double-arc RapidArc technique. The target volume and OARs were analyzed using dose-volume histograms (DVHs). The average MUs and the treatment time were used as markers to assess the efficacy of treatment delivery.
Results: The planning target volume parameters such as homogeneity and conformity index were similar for all the plans with both techniques. With IMRT, statistically significantly better sparing of I/L lung, heart, C/L breast, C/L lung, and esophagus were achieved as compared to RapidArc. We found that RapidArc resulted in significantly lower MUs (535.05 ± 105.42) than IMRT (913.57 ± 129.35). Treatment delivery time was statistically shorter with RapidArc as compared to IMRT (p=0.001). 
Conclusion: This study concluded that both IMRT and RapidArc plans have similar target coverage in terms of homogeneity and conformality indexes. Better OARs sparing was noticed with IMRT while RapidArc enabled higher efficacy with lower MUs and shorter treatment delivery time. However, further studies are needed to establish these dosimetric advantages being translated to improvements in the clinical outcomes of these patients. 


Main Subjects

  1. Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, et al. Global increase in breast cancer incidence: Risk factors and preventive measures. Biomed Res Int. 2022; 9605439.
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71: 209-49.
  3. International Agency for Research on Cancer: India source: Globocan. 2020.
  4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378: 1707-16.
  5. Early Breast Cancer Trialists’ Collaborative Group. McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383: 2127-35.
  6. Hufnagle JJ, Goyal A. Radiation therapy induce cardiac toxicity. Treasure island, FL: StatPearls Publishing LLC; 2020.
  7. Buwenge M, Cammelli S, Ammendolia I, Tolento G, Zamagni A, Arcelli A, et al. Intensity modulated radiation therapy for breast cancer: current perspectives. Breast Cancer. 2017; 9: 121-6.
  8. Infusino E. Clinical utility of RapidArc radiotherapy technology. Cancer Manag Res. 2015; 7: 345-56.
  9. Majumdar SK, Amritt A, Dhar SS, Barik S, Beura SS, Mishra T, et al. A dosimetric study comparing 3-DCRT vs. IMRT vs. VMAT in left-sided breast cancer patients after mastectomy at a tertiary care centre in Eastern India. Cureus. 2022; 14: e23568.
  10. Wang R, Shen J, Yan H, Gao X, Dong T, Li S, et al. Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy. Medicine. 2022; 101: e28427.
  11. RTOG Foundation. Philadelphia, PA: RTOG Foundation; c2018. Breast cancer atlas.
  12. Rastogi K, Sharma S, Gupta S, Agarwal N, Bhaskar S, Jain S. Dosimetric comparison of IMRT versus 3-DCRT for post-mastectomy chest wall irradiation. Radiat Oncol J. 2018; 36: 71-8.
  13. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010; 76: S10-9.
  14. Hodapp N. The ICRU report 83: prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy. Strahlenther Onkol. 2012; 188: 97-9.
  15. Feuvret L, Noel G, Mazeron JJ, Bey P. Conformality index: a review. Int J Radiat Oncol Biol Phys. 2006; 64: 333-42.
  16. Abshire D, Lang MK. The evolution of radiation therapy in treating cancer. Semin Oncol Nurs 2018; 34: 151-7.
  17. Atiq A, Atiq M, Iqbal K, Sial MA, Altaf S, Shamsi QA, et al. A comparative study of rapidArc and intensity-modulated radiotherapy plan quality for cervical cancer treatment. Indian J Cancer. 2018; 55: 74-9.
  18. Badakhshi H, Kaul D, Nadobny J, Wille B, Med C, Sehouli J, et al. Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol. 2013; 86: 20130515.
  19. Ansari S, Satpathy SK. An analysis of dose distribution in rapid arc and IMRT radiotherapy plan in the case of head and neck cancer using Ƴ-index. Int J Radiol Radiat Ther. 2019; 6: 65-8.
  20. Liu H, Chen X, He Z, Li J. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on the clinical dosimetric study. Computerized Med Image Graph. 2016; 54: 1-5.
  21. Guo M, Huang E, Liu X, Tang Y. Volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy in radical irradiation for cervical cancer without lymphadenectasis: Dosimetric and clinical results. Oncol Res Treat. 2018; 41: 105-9.
  22. Goswami B, Jain RK, Yadav S, Kumar S, Oommen S, Manocha S, et al. A dosimetric study of volumetric arc modulation with RapidArc versus intensity-modulated radiotherapy in cervical cancer patients. J Clin Diag Res. 2021; 15: XC01-05.
  23. Guy JB, Falk AT, Auberdiac P, Cartier L, Vallard A, Ollier E, et al. Dosimetric study of volumetric arc modulation with RapidArc and intensity-modulated radiotherapy in patients with cervical cancer and comparison with the 3-dimensional conformal technique for definitive radiotherapy in patients with cervical cancer. Med Dosim. 2016; 41: 9-14.
  24. Sharma MK, Mitra S, Saxena U, Bhushan M, Shrivastava H, Simson DK, et al. Is volumetric modulated arc therapy (RapidArc) better than intensity-modulated radiotherapy for gynecological malignancies? A dosimetric comparison. J Can Res Ther. 2014; 10: 883-8.
  25. Halder S, Saroj DK, Dixit A, Sarkar B, Yadav S. The feasibility of hybrid IMRT treatment planning for left-sided chest wall irradiation: A comparative treatment planning study. Iran J Med Phys 2023; 20: 31-41.
  26. Mehnati P, Ghorbanipoor M, Mohammadzadeh M, Nasiri BM, Mesbahi A. Predicting the risk of radiation pneumonitis and pulmonary function changes after breast cancer radiotherapy. J Biomed Phys Engi. 2021; 11: 459-64.
  27. Meng Y, Luo W, Wang W, Zhou C, Zhou S, Tang X, et al. Intermediate dose-volume parameters, not low-dose bath, is superior to predict radiation pneumonitis for lung cancer treated with intensity-modulated radiotherapy. Front Oncol 2020; 10: 584756.
  28. DeZorzi C. Radiation-induced coronary artery disease and its treatment: A quick review of current evidence. Cardiol Res Prac. 2018; 2018: 8367268.
  29. Cheng YJ, Nie XY, Ji CC, Lin XX, Liu LJ, Chen XM, et al. Long-term cardiovascular risk after radiotherapy in women with breast cancer. J Am Heart Assoc. 2017; 6: e005633.
  30. Chiuyo JS, Msaki PK, Makundi IN. Radiation dose to the contralateral breast and effectiveness of Superflab in dose reduction during treatment of breast cancer by cobalt-60 external beam. Tanz J Sci. 2020; 46: 873-85.
  31. Hu J, Han G, Lei Y, Xu X, Ge W, Ruan C, et al. Dosimetric comparison of three radiotherapy techniques in irradiation of left-sided breast cancer patients after radical mastectomy. Biomed Res Int. 2020; 2020: 7131590.
  32. Al-Rahbi ZS, Mandhari ZA, Ravichandran R, Al-Kindi F, Davis CA, Bhasi S, et al. Dosimetric comparison of intensity-modulated radiotherapy isocentric field plans and field in field forward plans in the treatment of breast cancer. J Med Phys. 2013; 38: 22-9.
  33. Sedeh NM, Pella S, Leventouri T, Littlejohn D, Costantino T. SU-E-T-693: Should we use RapidArc (VMAT) for breast treatments? A dosimetric comparison of IMRT versus VMAT optimization in whole breast irradiation of early-stage breast cancer.